BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15964654)

  • 1. Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
    Lim CJ; Shen WC
    J Control Release; 2005 Sep; 106(3):273-86. PubMed ID: 15964654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
    Xia CQ; Wang J; Shen WC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
    Xia CQ; Shen WC
    Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-oligomers as potential carriers in anticancer drug delivery.
    Lim CJ; Shen WC
    Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment of polarity and enhanced transcytosis of transferrin receptors in enterocyte-like Caco-2 cells.
    Shah D; Shen WC
    J Drug Target; 1994; 2(2):93-9. PubMed ID: 8069597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
    Kavimandan NJ; Losi E; Peppas NA
    Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells.
    Shah D; Shen WC
    J Pharm Sci; 1996 Dec; 85(12):1306-11. PubMed ID: 8961144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
    Visser CC; Stevanović S; Voorwinden LH; van Bloois L; Gaillard PJ; Danhof M; Crommelin DJ; de Boer AG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):299-305. PubMed ID: 15911226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice.
    Widera A; Bai Y; Shen WC
    Pharm Res; 2004 Feb; 21(2):278-84. PubMed ID: 15032309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
    Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
    Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
    Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
    Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.
    Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Preuss M; Zhou F; Siegal GP; Alvarez RD; Curiel DT
    Virology; 2004 Jul; 325(1):116-28. PubMed ID: 15231391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers.
    Widera A; Kim KJ; Crandall ED; Shen WC
    Pharm Res; 2003 Aug; 20(8):1231-8. PubMed ID: 12948021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-beta selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism.
    Testa U; Conti L; Sposi NM; Varano B; Tritarelli E; Malorni W; Samoggia P; Rainaldi G; Peschle C; Belardelli F
    J Immunol; 1995 Jul; 155(1):427-35. PubMed ID: 7602116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption.
    Lim CJ; Norouziyan F; Shen WC
    J Control Release; 2007 Oct; 122(3):393-8. PubMed ID: 17586083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats.
    Han J; Day JR; Connor JR; Beard JL
    Nutr Neurosci; 2003 Feb; 6(1):1-10. PubMed ID: 12608731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery.
    Du W; Fan Y; Zheng N; He B; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2013 Jan; 34(3):794-806. PubMed ID: 23103156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.